Journal of Neuro-Oncology

Aims & Scope

The Journal of Neuro-Oncology is a multi-disciplinary journal encompassing basic, applied, and clinical investigations in all research areas as they relate to cancer and the central nervous system.

It provides a single forum for communication among neurologists, neurosurgeons, radiotherapists, medical oncologists, neuropathologists, neurodiagnosticians, and laboratory-based oncologists conducting relevant research.

The Journal of Neuro-Oncology does not seek to isolate the field, but rather to focus the efforts of many disciplines in one publication through a format which pulls together these diverse interests.

More than any other field of oncology, cancer of the central nervous system requires multi-disciplinary approaches.

To alleviate having to scan dozens of journals of cell biology, pathology, laboratory and clinical endeavours, JNO is a periodical in which current, high-quality, relevant research in all aspects of neuro-oncology may be found.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.1
2024	3.20

Journal Rank

Year	Value
2024	3897

Journal Citation Indicator

Year	Value
2024	2753

SJR (SCImago Journal Rank)

Year	Value
2024	1.139

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	141

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Medicine and Neuroscience, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies

  Citation: 1183

  Authors: Johnny C., David, Ryan, Bob S., Clark C.

• Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

  Citation: 1172

  Authors: Klaus, Frank, Dirk, Hendrik, Peter, Burghard, Helmut, Volker, Andreas

• Epidemiology and etiology of meningioma

  Citation: 946

  Authors: Joseph, Margaret, Elizabeth B.

• Brain metastases: epidemiology and pathophysiology

  Citation: 764

  Authors: Igor T., Jerome B.

• Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma Multiforme

  Citation: 624

  Authors: Klaus, Ronny, Regina, Uwe, Peter, Burghard, Annelie, Andreas, Norbert, Roland, Andreas

• Glioblastoma survival in the United States before and during the temozolomide era

  Citation: 600

  Authors: Derek R., Brian Patrick

• Molecular Mechanisms of Glioma Cell Migration and Invasion

  Citation: 418

  Authors: Tim, Michael E.

• The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline

  Citation: 395

  Authors: Mark E., David W., Anthony L., Stuart H., Douglas, Paula D., Mario, Charles S., Laurie E., Jay S., Michael, Minesh P., Tom, Jeffrey J., Nina A., Roy A., Timothy C., Steven N.

• Improved survival time trends for glioblastoma using the SEER 17 population-based registries

  Citation: 392

  Authors: Matthew, John L., Therese A., Andrew, Usama, Steven J., Ralph R., Bridget J.

• Maximizing safe resection of low- and high-grade glioma

  Citation: 371

  Authors: Shawn L., Mitchel S.

---